{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T07:31:31Z","timestamp":1784705491547,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundations of China","doi-asserted-by":"crossref","award":["81974269"],"award-info":[{"award-number":["81974269"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15036-5","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:24:29Z","timestamp":1761042269000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical outcomes by bone metastasis uptake pattern in differentiated thyroid cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Guannan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"15036_CR1","doi-asserted-by":"publisher","first-page":"e465","DOI":"10.1097\/RLU.0000000000002626","volume":"44","author":"JD Kondraciuk","year":"2019","unstructured":"Kondraciuk JD, Rice SL, Zhou X, Gharzeddine K, Knezevic A, Spratt DE, et al. Thyroid cancer bone metastasis: survival and genomic characteristics of a large tertiary care cohort. Clin Nucl Med. 2019;44:e465\u201371.","journal-title":"Clin Nucl Med"},{"key":"15036_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1530\/EJE-16-0237","volume":"175","author":"YM Choi","year":"2016","unstructured":"Choi YM, Kim WG, Kwon H, Jeon MJ, Lee JJ, Ryu JS, et al. Early prognostic factors at the time of diagnosis of bone metastasis in patients with bone metastases of differentiated thyroid carcinoma. Eur J Endocrinol. 2016;175:165\u201372.","journal-title":"Eur J Endocrinol"},{"key":"15036_CR3","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1245\/s10434-012-2711-x","volume":"20","author":"BH Lang","year":"2013","unstructured":"Lang BH, Wong KP, Cheung CY, Wan KY, Lo CY. Evaluating the prognostic factors associated with cancer-specific survival of differentiated thyroid carcinoma presenting with distant metastasis. Ann Surg Oncol. 2013;20:1329\u201335.","journal-title":"Ann Surg Oncol"},{"key":"15036_CR4","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1093\/jjco\/hyu099","volume":"44","author":"R Nakayama","year":"2014","unstructured":"Nakayama R, Horiuchi K, Susa M, Watanabe I, Watanabe K, Tsuji T, et al. Clinical outcome after bone metastasis (BM) surgery in patients with differentiated thyroid carcinoma (DTC): a retrospective study of 40 cases. Jpn J Clin Oncol. 2014;44:918\u201325.","journal-title":"Jpn J Clin Oncol"},{"key":"15036_CR5","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1210\/jc.2005-2838","volume":"91","author":"C Durante","year":"2006","unstructured":"Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP, et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab. 2006;91:2892\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"15036_CR6","doi-asserted-by":"publisher","first-page":"E829","DOI":"10.1210\/jc.2012-3933","volume":"98","author":"MM Sabra","year":"2013","unstructured":"Sabra MM, Dominguez JM, Grewal RK, Larson SM, Ghossein RA, Tuttle RM, et al. Clinical outcomes and molecular profile of differentiated thyroid cancers with radioiodine-avid distant metastases. J Clin Endocrinol Metab. 2013;98:E829\u2013836.","journal-title":"J Clin Endocrinol Metab"},{"key":"15036_CR7","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.4158\/EP171924.OR","volume":"23","author":"D Hirsch","year":"2017","unstructured":"Hirsch D, Levy S, Tsvetov G, Gorshtein A, Slutzky-Shraga I, Akirov A, et al. Long-term outcomes and prognostic factors in patients with differentiated thyroid cancer and distant metastases. Endocr Pract. 2017;23:1193\u2013200.","journal-title":"Endocr Pract"},{"key":"15036_CR8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/hed.21504","volume":"33","author":"BM Barney","year":"2011","unstructured":"Barney BM, Hitchcock YJ, Sharma P, Shrieve DC, Tward JD. Overall and cause-specific survival for patients undergoing lobectomy, near-total, or total thyroidectomy for differentiated thyroid cancer. Head Neck. 2011;33:645\u20139.","journal-title":"Head Neck"},{"key":"15036_CR9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/cen.12558","volume":"82","author":"S Chopra","year":"2015","unstructured":"Chopra S, Garg A, Ballal S, Bal CS. Lung metastases from differentiated thyroid carcinoma: prognostic factors related to remission and disease-free survival. Clin Endocrinol (Oxf). 2015;82:445\u201352.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"15036_CR10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1530\/EJE-15-0296","volume":"173","author":"HJ Song","year":"2015","unstructured":"Song HJ, Qiu ZL, Shen CT, Wei WJ, Luo QY. Pulmonary metastases in differentiated thyroid cancer: efficacy of radioiodine therapy and prognostic factors. Eur J Endocrinol. 2015;173:399\u2013408.","journal-title":"Eur J Endocrinol"},{"key":"15036_CR11","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.2967\/jnumed.112.116426","volume":"54","author":"WP Fendler","year":"2013","unstructured":"Fendler WP, Philippe Tiega DB, Ilhan H, Paprottka PM, Heinemann V, Jakobs TF, et al. Validation of several SUV-based parameters derived from 18F-FDG PET for prediction of survival after SIRT of hepatic metastases from colorectal cancer. J Nucl Med. 2013;54:1202\u20138.","journal-title":"J Nucl Med"},{"key":"15036_CR12","doi-asserted-by":"publisher","first-page":"898","DOI":"10.2967\/jnumed.113.131847","volume":"55","author":"JW Lee","year":"2014","unstructured":"Lee JW, Kang CM, Choi HJ, Lee WJ, Song SY, Lee JH, et al. Prognostic value of metabolic tumor volume and total lesion glycolysis on preoperative (1)(8)F-FDG PET\/CT in patients with pancreatic cancer. J Nucl Med. 2014;55:898\u2013904.","journal-title":"J Nucl Med"},{"key":"15036_CR13","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.2967\/jnumed.112.116053","volume":"54","author":"IS Ryu","year":"2013","unstructured":"Ryu IS, Kim JS, Roh JL, Lee JH, Cho KJ, Choi SH, et al. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET\/CT in salivary gland carcinomas. J Nucl Med. 2013;54:1032\u20138.","journal-title":"J Nucl Med"},{"key":"15036_CR14","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s00259-017-3851-9","volume":"45","author":"C Li","year":"2018","unstructured":"Li C, Zhang J, Chen S, Huang S, Wu S, Zhang L, et al. Prognostic value of metabolic indices and bone marrow uptake pattern on preoperative 18F-FDG PET\/CT in pediatric patients with neuroblastoma. Eur J Nucl Med Mol Imaging. 2018;45:306\u201315.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"15036_CR15","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1210\/jc.2012-1533","volume":"97","author":"RC Webb","year":"2012","unstructured":"Webb RC, Howard RS, Stojadinovic A, Gaitonde DY, Wallace MK, Ahmed J, et al. The utility of serum thyroglobulin measurement at the time of remnant ablation for predicting disease-free status in patients with differentiated thyroid cancer: a meta-analysis involving 3947 patients. J Clin Endocrinol Metab. 2012;97:2754\u201363.","journal-title":"J Clin Endocrinol Metab"},{"key":"15036_CR16","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1210\/jc.2011-0093","volume":"96","author":"ZL Qiu","year":"2011","unstructured":"Qiu ZL, Song HJ, Xu YH, Luo QY. Efficacy and survival analysis of 131I therapy for bone metastases from differentiated thyroid cancer. J Clin Endocrinol Metab. 2011;96:3078\u201386.","journal-title":"J Clin Endocrinol Metab"},{"key":"15036_CR17","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1148\/radiol.2016142043","volume":"280","author":"JH O","year":"2016","unstructured":"O JH, Lodge MA, Wahl RL. Practical PERCIST. A simplified guide to PET response criteria in solid tumors 1.0. Radiology. 2016;280:576\u201384.","journal-title":"Radiology"},{"key":"15036_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5441-7","volume":"19","author":"S Ye","year":"2019","unstructured":"Ye S, Liu S, Xiang L, Wu X, Yang H. (18)F-fdg pet\/ct-based metabolic metrics in recurrent tumors of ovarian clear cell carcinoma and their prognostic implications. BMC Cancer. 2019;19:226.","journal-title":"BMC Cancer"},{"key":"15036_CR19","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-17-0453","volume":"25","author":"L Lamartina","year":"2018","unstructured":"Lamartina L, Grani G, Arvat E, Nervo A, Zatelli MC, Rossi R, et al. 8th edition of the AJCC\/TNM staging system of thyroid cancer: what to expect (ITCO#2). Endocr Relat Cancer. 2018;25:L7-L11.","journal-title":"Endocr Relat Cancer"},{"key":"15036_CR20","doi-asserted-by":"publisher","first-page":"s6243","DOI":"10.1158\/1078-0432.CCR-06-0931","volume":"12","author":"RE Coleman","year":"2006","unstructured":"Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12:s6243\u20139.","journal-title":"Clin Cancer Res"},{"key":"15036_CR21","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1","volume":"83","author":"SA Hundahl","year":"1998","unstructured":"Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A national cancer data base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985\u20131995. Cancer. 1998;83:2638\u201348.","journal-title":"Cancer"},{"key":"15036_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1677\/ERC-07-0229","volume":"15","author":"MM Muresan","year":"2008","unstructured":"Muresan MM, Olivier P, Leclere J, Sirveaux F, Brunaud L, Klein M, et al. Bone metastases from differentiated thyroid carcinoma. Endocr Relat Cancer. 2008;15:37\u201349.","journal-title":"Endocr Relat Cancer"},{"key":"15036_CR23","doi-asserted-by":"publisher","first-page":"e0173354","DOI":"10.1371\/journal.pone.0173354","volume":"12","author":"JD Lin","year":"2017","unstructured":"Lin JD, Lin SF, Chen ST, Hsueh C, Li CL, Chao TC. Long-term follow-up of papillary and follicular thyroid carcinomas with bone metastasis. PLoS ONE. 2017;12:e0173354.","journal-title":"PLoS ONE"},{"key":"15036_CR24","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/hed.24655","volume":"39","author":"M Osorio","year":"2017","unstructured":"Osorio M, Moubayed SP, Su H, Urken ML. Systematic review of site distribution of bone metastases in differentiated thyroid cancer. Head Neck. 2017;39:812\u20138.","journal-title":"Head Neck"},{"key":"15036_CR25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.oraloncology.2018.08.013","volume":"85","author":"N Moeckelmann","year":"2018","unstructured":"Moeckelmann N, Ebrahimi A, Tou YK, Gupta R, Low TH, Ashford B, et al. Prognostic implications of the 8th edition American joint committee on cancer (AJCC) staging system in oral cavity squamous cell carcinoma. Oral Oncol. 2018;85:82\u20136.","journal-title":"Oral Oncol"},{"key":"15036_CR26","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1007\/s00268-013-2213-4","volume":"37","author":"HJ Kim","year":"2013","unstructured":"Kim HJ, Lee JI, Kim NK, Min YK, Kim SW, Chung JH. Prognostic implications of radioiodine avidity and serum thyroglobulin in differentiated thyroid carcinoma with distant metastasis. World J Surg. 2013;37:2845\u201352.","journal-title":"World J Surg"},{"key":"15036_CR27","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1365-2265.2011.04231.x","volume":"76","author":"IC Huang","year":"2012","unstructured":"Huang IC, Chou FF, Liu RT, Tung SC, Chen JF, Kuo MC, et al. Long-term outcomes of distant metastasis from differentiated thyroid carcinoma. Clin Endocrinol (Oxf). 2012;76:439\u201347.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"15036_CR28","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20180136","volume":"91","author":"PS Choudhury","year":"2018","unstructured":"Choudhury PS, Gupta M. Differentiated thyroid cancer theranostics: radioiodine and beyond. Br J Radiol. 2018;91:20180136.","journal-title":"Br J Radiol"},{"key":"15036_CR29","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1007\/s00259-022-05697-w","volume":"49","author":"A Jannin","year":"2022","unstructured":"Jannin A, Lamartina L, Moutarde C, Djennaoui M, Lion G, Chevalier B, et al. Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive iodine therapy and overall survival. Eur J Nucl Med Mol Imaging. 2022;49:2401\u201313.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"15036_CR30","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s12149-021-01664-x","volume":"35","author":"Y Uchiyama","year":"2021","unstructured":"Uchiyama Y, Hirata K, Watanabe S, Okamoto S, Shiga T, Okada K, et al. Development and validation of a prediction model based on the organ-based metabolic tumor volume on FDG-PET in patients with differentiated thyroid carcinoma. Ann Nucl Med. 2021;35:1223\u201331.","journal-title":"Ann Nucl Med"},{"key":"15036_CR31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.remnie.2016.01.009","volume":"35","author":"M Mayoral","year":"2016","unstructured":"Mayoral M, Fernandez-Martinez A, Vidal L, Fuster D, Aya F, Pavia J, et al. Prognostic value of (18)F-FDG PET\/CT volumetric parameters in recurrent epithelial ovarian cancer. Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition). 2016;35:88\u201395.","journal-title":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15036-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15036-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15036-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:03:06Z","timestamp":1761087786000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-15036-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15036"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15036-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine. The data used in this study were fully desensitized at the time of extraction to strictly protect patients\u2019 private information. The investigator has applied to the ethics committee for exemption from informed consent and has been approved.\u00a0We have also certified that the study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1617"}}